Stria distensa. Striae atrophicae
Conditions
Interventions
Intervention 1: Intervention group: Combination of microneedling and Basic Fibroblas Growth Factor (BFGF) in the treatment of stria distensae (each month three sessions). Intervention 2: Control group
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patents between 18 and 60 years old
Exclusion criteria
Exclusion criteria: Pregnant women Lactating women Diabetic Hypertension Hypothyroidism Hyperthyroidism Immunosuppressed patients Patients who recieved stria treatment 3 months ago or have infection on the stria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical improvement stria. Timepoint: Patients will be visited 4 times, 0, 1, 2, 5 month. Method of measurement: The GAIS(Global Aesthetic Improvement Scale) is measured as follows:Grade 0: worsening of lesions Grade1: No change (< 25% improvement)Grade 2: Improved (25-50% improvement)Grade 3: Much improved (51-75% improvement)Grade 4: Very much improved (76-100% improvement). | — |
Secondary
| Measure | Time frame |
|---|---|
| Stria size reduction. Timepoint: Patients will be visited 4 times, 0, 1, 2, 5 month. Method of measurement: Rate of width reduction (%)=Baseline width-Follow upwidth/Baseline width ×100.;Stria color. Timepoint: Patients will be visited 4 times, 0, 1, 2, 5 month. Method of measurement: Melanin index is measured bySkinColorCatch colorimeter(Delphin, Finland) and is presentedas average of .3 points measure.;Patient satisfaction. Timepoint: Patients will be visited 4 times, 0, 1, 2, 5 month. Method of measurement: Patient satisfaction is assessed by a 5point scale: 4: Extremely satisfied3: Very satisfied 2: satisfied 1:Slightly satisfied 0: Not satisfied. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRahil Hamedpour
Shiraz University of Medical Sciences
Outcome results
None listed